Influence of clinical communication on patients' decision making on participation in clinical trials
- PMID: 18509178
- PMCID: PMC3807688
- DOI: 10.1200/JCO.2007.14.8114
Influence of clinical communication on patients' decision making on participation in clinical trials
Abstract
Purpose: To investigate how communication among physicians, patients, and family/companions influences patients' decision making about participation in clinical trials.
Patients and methods: We video recorded 235 outpatient interactions occurring among oncologists, patients, and family/companions (if present) at two comprehensive cancer centers. We combined interaction analysis of the real-time video-recorded observations (collected at Time 1) with patient self-reports (Time 2) to determine how communication about trial offers influenced accrual decisions.
Results: Clinical trials were explicitly offered in 20% of the interactions. When offers were made and patients perceived they were offered a trial, 75% of patients assented. Observed messages (at Time 1) directly related to patients' self-reports regarding their decisions (2 weeks later), and how they felt about their decisions and their physicians. Specifically, messages that help build a sense of an alliance (among all parties, including the family/companions), provide support (tangible assistance and reassurance about managing adverse effects), and provide medical content in language that patients and family/companions understand are associated with the patient's decision and decision-making process.
Conclusion: In two urban, National Cancer Institute-designated comprehensive cancer centers, a large percentage of patients are not offered trials. When offered a trial, most patients enroll. The quality and quantity of communication occurring among the oncologist, patient, and family/companion when trials are discussed matter in the patient's decision-making process. These findings can help increase physician awareness of the ways that messages and communication behaviors can be observed and evaluated to improve clinical practice and research.
Conflict of interest statement
Comment in
-
Why learning to communicate with our patients is so important: using communication to enhance accrual to cancer clinical trials.J Clin Oncol. 2008 Jun 1;26(16):2614-5. doi: 10.1200/JCO.2008.16.2610. J Clin Oncol. 2008. PMID: 18509171 No abstract available.
Similar articles
-
Partnering around cancer clinical trials (PACCT): study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials.BMC Cancer. 2017 Dec 2;17(1):807. doi: 10.1186/s12885-017-3804-5. BMC Cancer. 2017. PMID: 29197371 Free PMC article. Clinical Trial.
-
Patients' perceptions of physicians communication and outcomes of the accrual to trial process.Health Commun. 2000;12(1):23-39. doi: 10.1207/S15327027HC1201_02. Health Commun. 2000. PMID: 10938905
-
Realizing better doctor-patient dialogue about choices in palliative care and early phase clinical trial participation: towards an online value clarification tool (OnVaCT).BMC Palliat Care. 2019 Nov 29;18(1):106. doi: 10.1186/s12904-019-0486-6. BMC Palliat Care. 2019. PMID: 31783851 Free PMC article.
-
Cancer patient decision making related to clinical trial participation: an integrative review with implications for patients' relational autonomy.Support Care Cancer. 2015 Apr;23(4):1169-96. doi: 10.1007/s00520-014-2581-9. Epub 2015 Jan 17. Support Care Cancer. 2015. PMID: 25591627 Review.
-
Communication and consumer decision making about cancer clinical trials.Patient Educ Couns. 2003 May;50(1):39-42. doi: 10.1016/s0738-3991(03)00078-8. Patient Educ Couns. 2003. PMID: 12767583 Review.
Cited by
-
Color-Blind and Multicultural Strategies in Medical Settings.Soc Issues Policy Rev. 2017 Jan;11(1):124-158. doi: 10.1111/sipr.12029. Epub 2017 Jan 13. Soc Issues Policy Rev. 2017. PMID: 39359747 Free PMC article.
-
Racial Differences Among Factors Associated with Participation in Clinical Research Trials.J Racial Ethn Health Disparities. 2016 Sep 8. doi: 10.1007/s40615-016-0285-1. Online ahead of print. J Racial Ethn Health Disparities. 2016. PMID: 27631379
-
Clinical trial awareness: Changes over time and sociodemographic disparities.Clin Trials. 2015 Jun;12(3):215-23. doi: 10.1177/1740774515571917. Epub 2015 Feb 10. Clin Trials. 2015. PMID: 25673636 Free PMC article.
-
Donating tissue for research: patient and provider perspectives.J Oncol Pract. 2011 Sep;7(5):334-7. doi: 10.1200/JOP.2011.000399. J Oncol Pract. 2011. PMID: 22211133 Free PMC article.
-
Public knowledge and information sources for clinical trials among adults in the USA: evidence from a Health Information National Trends Survey in 2020.Clin Med (Lond). 2022 Sep;22(5):416-422. doi: 10.7861/clinmed.2022-0107. Epub 2022 Aug 10. Clin Med (Lond). 2022. PMID: 36507814 Free PMC article.
References
-
- Avis NE, Smith KW, Link CL, et al. Factors associated with participation in breast cancer treatment clinical trials. J Clin Oncol. 2006;24:1860–1867. - PubMed
-
- Giuliano AR, Mokuau N, Hughes C, et al. Participation of minorities in cancer research: The influence of structural, cultural, and linguistic factors. Ann Epidemiol. 2000;10:S22–S34. - PubMed
-
- Wetzig NR, Gill PG, Ung O, et al. Participation in the RACS sentinel node biopsy versus axillary clearance trial. ANZ J Surg. 2005;75:98–100. - PubMed
-
- Kimmick GG, Peterson BL, Kornblith AB, et al. Improving accrual of older persons to cancer treatment trials: A randomized trial comparing an educational intervention with standard information—CALGB 360001. J Clin Oncol. 2005;23:2201–2207. - PubMed
-
- Martel CL, Li Y, Beckett L, et al. An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California. Cancer J. 2004;10:294–300. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical